Draft Documents to Support Submission of an Electronic Common Technical Document; Availability

Document ID: FDA-2011-N-0724-0001

Comments

Total: 8
GlaxoSmithKline - Comment
Posted : 12/22/2011     ID :FDA-2011-N-0724-0002     Agency : FDA

Dec 27,2011 11:59 PM ET
Sanofi - Comment
Posted : 12/22/2011     ID :FDA-2011-N-0724-0003     Agency : FDA

Dec 27,2011 11:59 PM ET
MacroGenics, Inc. - Comment
Posted : 01/05/2012     ID :FDA-2011-N-0724-0004     Agency : FDA

Dec 27,2011 11:59 PM ET
Boehringer Ingelheim Pharmaceuticals, Inc. - Comment
Posted : 01/05/2012     ID :FDA-2011-N-0724-0005     Agency : FDA

Dec 27,2011 11:59 PM ET
Pharmaceutical Research and Manufacturers of America (PhRMA) - Comment
Posted : 01/05/2012     ID :FDA-2011-N-0724-0006     Agency : FDA

Dec 27,2011 11:59 PM ET
IRISS - Comment
Posted : 01/05/2012     ID :FDA-2011-N-0724-0007     Agency : FDA

Dec 27,2011 11:59 PM ET
Biologics Consulting Group - Comment
Posted : 01/05/2012     ID :FDA-2011-N-0724-0008     Agency : FDA

Dec 27,2011 11:59 PM ET
Liquent - Comment
Posted : 01/05/2012     ID :FDA-2011-N-0724-0009     Agency : FDA

Dec 27,2011 11:59 PM ET